Meiragtx Holdings Plc Stock Alpha and Beta Analysis
| MGTX Stock | USD 6.95 0.11 1.61% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as MeiraGTx Holdings PLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in MeiraGTx Holdings over a specified time horizon. Remember, high MeiraGTx Holdings' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to MeiraGTx Holdings' market risk premium analysis include:
Beta 0.54 | Alpha 0.35 | Risk 3.61 | Sharpe Ratio 0.0078 | Expected Return 0.0283 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
MeiraGTx |
MeiraGTx Holdings Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. MeiraGTx Holdings market risk premium is the additional return an investor will receive from holding MeiraGTx Holdings long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in MeiraGTx Holdings. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate MeiraGTx Holdings' performance over market.| α | 0.35 | β | 0.54 |
MeiraGTx Holdings expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of MeiraGTx Holdings' Buy-and-hold return. Our buy-and-hold chart shows how MeiraGTx Holdings performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.MeiraGTx Holdings Market Price Analysis
Market price analysis indicators help investors to evaluate how MeiraGTx Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MeiraGTx Holdings shares will generate the highest return on investment. By understating and applying MeiraGTx Holdings stock market price indicators, traders can identify MeiraGTx Holdings position entry and exit signals to maximize returns.
MeiraGTx Holdings Return and Market Media
The median price of MeiraGTx Holdings for the period between Sat, Nov 9, 2024 and Fri, Feb 7, 2025 is 6.22 with a coefficient of variation of 5.19. The daily time series for the period is distributed with a sample standard deviation of 0.32, arithmetic mean of 6.25, and mean deviation of 0.25. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | MeiraGTx Holdings plc Analysts Are Cutting Their Estimates Heres What You Need To Know | 11/15/2024 |
2 | Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors | 11/25/2024 |
3 | Garden State Investment Advisory Services LLC Makes New 1.64 Million Investment in MeiraGTx Holdings plc | 12/02/2024 |
4 | MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 23 Radiation-Induced Xerostomia | 12/09/2024 |
5 | MeiraGTxs SWOT analysis gene therapy firms stock faces clinical hurdles - Investing.com | 12/17/2024 |
6 | Disposition of 52500 shares by Giroux Richard of MeiraGTx Holdings subject to Rule 16b-3 | 01/07/2025 |
7 | Disposition of 11661 shares by Alexandria Forbes of MeiraGTx Holdings at 6.3 subject to Rule 16b-3 | 01/08/2025 |
8 | Acquisition by Stuart Naylor of 37500 shares of MeiraGTx Holdings subject to Rule 16b-3 | 01/10/2025 |
9 | Disposition of 30000 shares by Alexandria Forbes of MeiraGTx Holdings subject to Rule 16b-3 | 01/14/2025 |
10 | Disposition of 24000 shares by Giroux Richard of MeiraGTx Holdings at 6.29 subject to Rule 16b-3 | 01/21/2025 |
11 | MeiraGTx Receives Rare Pediatric Disease Designation from FDA for AAV8-RK-RetGC for the Treatment of Patients with Leber Congenital Amaurosis due to GUCY2D Muta... | 01/22/2025 |
12 | Strong week for MeiraGTx Holdings shareholders doesnt alleviate pain of five-year loss | 02/06/2025 |
About MeiraGTx Holdings Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including MeiraGTx or other stocks. Alpha measures the amount that position in MeiraGTx Holdings PLC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2024 | 2025 (projected) | Payables Turnover | 0.52 | 0.47 | 0.31 | Days Of Inventory On Hand | 340.31 | 391.36 | 393.76 |
MeiraGTx Holdings Upcoming Company Events
As portrayed in its financial statements, the presentation of MeiraGTx Holdings' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MeiraGTx Holdings' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of MeiraGTx Holdings' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of MeiraGTx Holdings. Please utilize our Beneish M Score to check the likelihood of MeiraGTx Holdings' management manipulating its earnings.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with MeiraGTx Holdings
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for MeiraGTx Stock Analysis
When running MeiraGTx Holdings' price analysis, check to measure MeiraGTx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MeiraGTx Holdings is operating at the current time. Most of MeiraGTx Holdings' value examination focuses on studying past and present price action to predict the probability of MeiraGTx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MeiraGTx Holdings' price. Additionally, you may evaluate how the addition of MeiraGTx Holdings to your portfolios can decrease your overall portfolio volatility.